obinutuzumab FDA approval date

The FDA approved obinutuzumab on 1 Nov 2013.

FDA approval date
1 Nov 2013

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesNCT07520006NRIXPhase 1, Phase 2Recruiting2033-05Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2013-11-01DayobinutuzumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125486", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["GAZYVA"], "active_ingredients": ["OBINUTUZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131101", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 26 Oct 2026 · Evidence last checked: 26 Oct 2026